Papers: 10.3390/cancers12071995

https://doi.org/10.3390/cancers12071995

Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors?

Cited by: 6
Author(s): Nagio Takigawa, Nobuaki Ochi, Nozomu Nakagawa, Yasunari Nagasaki, Masataka Taoka, Naruhiko Ichiyama, Ayaka Mimura, Hiroyuki Nakanishi, Hiroyuki Kohara, Hiromichi Yamane
Published: about 6 years ago

Software Mentions 1